Advertisement TGA approves Aurobindo Pharma schizophrenia, osteoporosis drugs - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

TGA approves Aurobindo Pharma schizophrenia, osteoporosis drugs

The Australian Therapeutic Goods Administration (TGA) has granted approval to Aurobindo Pharma Limited's wholly owned subsidiary Aurobindo Pharma Australia to register Risperidone tablets 0.5mg, 1mg, 2mg, 3mg, 4mg and Oral Solution 1mg/1ml and Alendronate tablets 70mg in Australia.

Risperidone is an atypical antipsychotic that works by affecting certain substances in the brain.

Risperidone tablets and Oral Solution are indicated for the treatment of schizophrenia.

Alendronate tablets 70mg are used for the treatment and prevention of osteoporosis.